Mobile-based oral cancer classification for point-of-care screening.
dual-modality
efficient deep learning
mobile screening device
oral cancer
Journal
Journal of biomedical optics
ISSN: 1560-2281
Titre abrégé: J Biomed Opt
Pays: United States
ID NLM: 9605853
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
07
04
2021
accepted:
08
06
2021
entrez:
24
6
2021
pubmed:
25
6
2021
medline:
25
9
2021
Statut:
ppublish
Résumé
Oral cancer is among the most common cancers globally, especially in low- and middle-income countries. Early detection is the most effective way to reduce the mortality rate. Deep learning-based cancer image classification models usually need to be hosted on a computing server. However, internet connection is unreliable for screening in low-resource settings. To develop a mobile-based dual-mode image classification method and customized Android application for point-of-care oral cancer detection. The dataset used in our study was captured among 5025 patients with our customized dual-modality mobile oral screening devices. We trained an efficient network MobileNet with focal loss and converted the model into TensorFlow Lite format. The finalized lite format model is ∼16.3 MB and ideal for smartphone platform operation. We have developed an Android smartphone application in an easy-to-use format that implements the mobile-based dual-modality image classification approach to distinguish oral potentially malignant and malignant images from normal/benign images. We investigated the accuracy and running speed on a cost-effective smartphone computing platform. It takes ∼300 ms to process one image pair with the Moto G5 Android smartphone. We tested the proposed method on a standalone dataset and achieved 81% accuracy for distinguishing normal/benign lesions from clinically suspicious lesions, using a gold standard of clinical impression based on the review of images by oral specialists. Our study demonstrates the effectiveness of a mobile-based approach for oral cancer screening in low-resource settings.
Identifiants
pubmed: 34164967
pii: JBO-210101R
doi: 10.1117/1.JBO.26.6.065003
pmc: PMC8220969
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIDCR NIH HHS
ID : R01 DE030682
Pays : United States
Organisme : NIBIB NIH HHS
ID : UH2 EB022623
Pays : United States
Organisme : NCI NIH HHS
ID : UH3 CA239682
Pays : United States
Références
JAMA. 2018 Sep 18;320(11):1101-1102
pubmed: 30178065
J Am Dent Assoc. 2010 Feb;141(2):151-6
pubmed: 20123872
Nature. 2015 May 28;521(7553):436-44
pubmed: 26017442
Nature. 2017 Feb 2;542(7639):115-118
pubmed: 28117445
J Int Med Res. 2010 May-Jun;38(3):737-49
pubmed: 20819411
Sci Rep. 2017 Sep 20;7(1):11979
pubmed: 28931888
Eur J Cancer Prev. 2012 Sep;21(5):460-6
pubmed: 22217551
Clin Cancer Res. 2008 Apr 15;14(8):2396-404
pubmed: 18413830
Br Dent J. 2017 Apr 7;222(7):497
pubmed: 28387269
Brief Bioinform. 2018 Nov 27;19(6):1236-1246
pubmed: 28481991
Biomed Opt Express. 2018 Oct 10;9(11):5318-5329
pubmed: 30460130
Head Neck. 2012 Jun;34(6):856-62
pubmed: 21818819
J Biomed Opt. 2019 Oct;24(10):1-8
pubmed: 31642247
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Biomed Opt. 2017 Jun 1;22(6):60503
pubmed: 28655055
PLoS One. 2018 Dec 5;13(12):e0207493
pubmed: 30517120
Indian J Cancer. 2019 Apr-Jun;56(2):107-113
pubmed: 31062727
Adv Dent Res. 2011 May;23(2):237-46
pubmed: 21490236
CA Cancer J Clin. 2017 Jan;67(1):51-64
pubmed: 28076666
Oral Oncol. 2009 Apr-May;45(4-5):454-60
pubmed: 18804412
J Natl Cancer Inst. 2019 Sep 1;111(9):923-932
pubmed: 30629194
Biosci Rep. 2018 Nov 28;38(6):
pubmed: 30341239
J Cancer Epidemiol. 2012;2012:701932
pubmed: 23093961
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593